{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:04:11Z","timestamp":1792789451000,"version":"4.5.0"},"reference-count":227,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,1,22]],"date-time":"2023-01-22T00:00:00Z","timestamp":1674345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute of Health","award":["RO1 AG051574"],"award-info":[{"award-number":["RO1 AG051574"]}]},{"name":"National Institute of Health","award":["RF1 AG068034"],"award-info":[{"award-number":["RF1 AG068034"]}]},{"name":"National Institute of Health","award":["AG068034-0LS1"],"award-info":[{"award-number":["AG068034-0LS1"]}]},{"name":"National Institute of Health","award":["HL143519"],"award-info":[{"award-number":["HL143519"]}]},{"name":"National Institute of Health","award":["2P20 GM109024"],"award-info":[{"award-number":["2P20 GM109024"]}]},{"name":"National Institute of Health","award":["U54GM128729"],"award-info":[{"award-number":["U54GM128729"]}]},{"DOI":"10.13039\/100000002","name":"National Institute of Health","doi-asserted-by":"publisher","award":["RO1 AG051574"],"award-info":[{"award-number":["RO1 AG051574"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institute of Health","doi-asserted-by":"publisher","award":["RF1 AG068034"],"award-info":[{"award-number":["RF1 AG068034"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institute of Health","doi-asserted-by":"publisher","award":["AG068034-0LS1"],"award-info":[{"award-number":["AG068034-0LS1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institute of Health","doi-asserted-by":"publisher","award":["HL143519"],"award-info":[{"award-number":["HL143519"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institute of Health","doi-asserted-by":"publisher","award":["2P20 GM109024"],"award-info":[{"award-number":["2P20 GM109024"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institute of Health","doi-asserted-by":"publisher","award":["U54GM128729"],"award-info":[{"award-number":["U54GM128729"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIGMS COBRE","doi-asserted-by":"publisher","award":["RO1 AG051574"],"award-info":[{"award-number":["RO1 AG051574"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIGMS COBRE","doi-asserted-by":"publisher","award":["RF1 AG068034"],"award-info":[{"award-number":["RF1 AG068034"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIGMS COBRE","doi-asserted-by":"publisher","award":["AG068034-0LS1"],"award-info":[{"award-number":["AG068034-0LS1"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIGMS COBRE","doi-asserted-by":"publisher","award":["HL143519"],"award-info":[{"award-number":["HL143519"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIGMS COBRE","doi-asserted-by":"publisher","award":["2P20 GM109024"],"award-info":[{"award-number":["2P20 GM109024"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIGMS COBRE","doi-asserted-by":"publisher","award":["U54GM128729"],"award-info":[{"award-number":["U54GM128729"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DaCCoTA CTR","award":["RO1 AG051574"],"award-info":[{"award-number":["RO1 AG051574"]}]},{"name":"DaCCoTA CTR","award":["RF1 AG068034"],"award-info":[{"award-number":["RF1 AG068034"]}]},{"name":"DaCCoTA CTR","award":["AG068034-0LS1"],"award-info":[{"award-number":["AG068034-0LS1"]}]},{"name":"DaCCoTA CTR","award":["HL143519"],"award-info":[{"award-number":["HL143519"]}]},{"name":"DaCCoTA CTR","award":["2P20 GM109024"],"award-info":[{"award-number":["2P20 GM109024"]}]},{"name":"DaCCoTA CTR","award":["U54GM128729"],"award-info":[{"award-number":["U54GM128729"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Hypertension is a major health concern globally. Elevated blood pressure, initiated and maintained by the brain, is defined as neurogenic hypertension (NH), which accounts for nearly half of all hypertension cases. A significant increase in angiotensin II-mediated sympathetic nervous system activity within the brain is known to be the key driving force behind NH. Blood pressure control in NH has been demonstrated through intracerebrovascular injection of agents that reduce the sympathetic influence on cardiac functions. However, traditional antihypertensive agents lack effective brain permeation, making NH management extremely challenging. Therefore, developing strategies that allow brain-targeted delivery of antihypertensives at the therapeutic level is crucial. Targeting nanotherapeutics have become popular in delivering therapeutics to hard-to-reach regions of the body, including the brain. Despite the frequent use of nanotherapeutics in other pathological conditions such as cancer, their use in hypertension has received very little attention. This review discusses the underlying pathophysiology and current management strategies for NH, as well as the potential role of targeted therapeutics in improving current treatment strategies.<\/jats:p>","DOI":"10.3390\/ijms24032213","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T03:21:54Z","timestamp":1674616914000},"page":"2213","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Neurogenic Hypertension, the Blood\u2013Brain Barrier, and the Potential Role of Targeted Nanotherapeutics"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9659-9083","authenticated-orcid":false,"given":"Richard Nii Lante","family":"Lamptey","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, School of Pharmacy, College of Health Professions, North Dakota State University, Fargo, ND 58105, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5889-8448","authenticated-orcid":false,"given":"Chengwen","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, School of Pharmacy, College of Health Professions, North Dakota State University, Fargo, ND 58105, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2457-7619","authenticated-orcid":false,"given":"Buddhadev","family":"Layek","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, School of Pharmacy, College of Health Professions, North Dakota State University, Fargo, ND 58105, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagdish","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, School of Pharmacy, College of Health Professions, North Dakota State University, Fargo, ND 58105, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Paton, J.F., and Raizada, M.K. (2010). Neurogenic Hypertension, Wiley Online Library.","DOI":"10.1113\/expphysiol.2009.047282"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/s41440-020-0492-3","article-title":"Connecting sympathetic and renin\u2013angiotensin system overdrive in neurogenic hypertension through miRNA-181a","volume":"43","author":"Biancardi","year":"2020","journal-title":"Hypertens. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/practneurol-2019-002269","article-title":"Blood pressure and the brain: The neurology of hypertension","volume":"20","author":"Kelly","year":"2020","journal-title":"Pract. Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.semnephrol.2005.02.002","article-title":"Systemic hypertension: An overview of the problem","volume":"25","author":"Kaplan","year":"2005","journal-title":"Semin. Nephrol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1080\/14779072.2018.1540301","article-title":"Pathophysiology of essential hypertension: An update","volume":"16","author":"Saxena","year":"2018","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/S0140-6736(03)13302-8","article-title":"Essential hypertension","volume":"361","author":"Staessen","year":"2003","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10286-018-0541-z","article-title":"Neurogenic hypertension: Pathophysiology, diagnosis and management","volume":"28","author":"Mann","year":"2018","journal-title":"Clin. Auton. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrn1902","article-title":"The sympathetic control of blood pressure","volume":"7","author":"Guyenet","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/HYPERTENSIONAHA.117.08936","article-title":"Recent advances in neurogenic hypertension: Dietary salt, obesity, and inflammation","volume":"70","author":"Stocker","year":"2017","journal-title":"Hypertension"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0140-6736(14)61468-9","article-title":"Hypertension","volume":"386","author":"Poulter","year":"2015","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00109-008-0324-4","article-title":"Signalling across the blood brain barrier by angiotensin II: Novel implications for neurogenic hypertension","volume":"86","author":"Paton","year":"2008","journal-title":"J. Mol. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"F533","DOI":"10.1152\/ajprenal.1984.246.5.F533","article-title":"Actions of angiotensin II on the brain: Mechanisms and physiologic role","volume":"246","author":"Reid","year":"1984","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/BF01952643","article-title":"Intracerebroventricular angiotensin II increases arterial blood pressure in rhesus monkeys by stimulation of pituitary hormones and the sympathetic nervous system","volume":"38","author":"Jung","year":"1982","journal-title":"Experientia"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s11906-007-0041-3","article-title":"Circulating angiotensin II and dietary salt: Converging signals for neurogenic hypertension","volume":"9","author":"Osborn","year":"2007","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00041552-200203000-00011","article-title":"Sympathetic nervous system and the kidney in hypertension","volume":"11","author":"Dibona","year":"2002","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1113\/expphysiol.2009.047407","article-title":"Angiotensin-converting enzyme 2: A new target for neurogenic hypertension","volume":"95","author":"Feng","year":"2010","journal-title":"Exp. Physiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/HYPERTENSIONAHA.120.16002","article-title":"Central Ang II (Angiotensin II)-mediated sympathoexcitation: Role for HIF-1\u03b1 (hypoxia-inducible factor-1\u03b1) facilitated glutamatergic tone in the paraventricular nucleus of the hypothalamus","volume":"77","author":"Sharma","year":"2021","journal-title":"Hypertension"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"9960","DOI":"10.1073\/pnas.93.18.9960","article-title":"Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotensin type 1 receptor antisense","volume":"93","author":"Iyer","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1524-6175.2007.07161.x","article-title":"Centrally acting antihypertensive agents: An update","volume":"9","author":"Sica","year":"2007","journal-title":"J. Clin. Hypertens."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"455S","DOI":"10.1111\/j.1365-2125.1983.tb00316.x","article-title":"The pharmacology of centrally acting antihypertensive drugs","volume":"15","author":"Thoolen","year":"1983","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3109\/10641969909061015","article-title":"Centrally acting antihypertensive drugs. Present and future","volume":"21","year":"1999","journal-title":"Clin. Exp. Hypertens."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1124\/jpet.119.264127","article-title":"Dual-modified liposome for targeted and enhanced gene delivery into mice brain","volume":"374","author":"Lakkadwala","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.biomaterials.2012.09.047","article-title":"Brain-targeted delivery of protein using chitosan-and RVG peptide-conjugated, pluronic-based nano-carrier","volume":"34","author":"Kim","year":"2013","journal-title":"Biomaterials"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12951-016-0177-x","article-title":"Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E","volume":"14","author":"Neves","year":"2016","journal-title":"J. Nanobiotechnology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1049\/iet-nbt.2018.5322","article-title":"Brain targeted delivery of anticancer drugs: Prospective approach using solid lipid nanoparticles","volume":"13","author":"Anand","year":"2019","journal-title":"IET Nanobiotechnology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"121095","DOI":"10.1016\/j.ijpharm.2021.121095","article-title":"In vitro and in vivo optimization of liposomal nanoparticles based brain targeted vgf gene therapy","volume":"608","author":"Arora","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00000658-198503000-00023","article-title":"Neurogenic hypertension: Etiology and surgical treatment. I. Observations in 53 patients","volume":"201","author":"Jannetta","year":"1985","journal-title":"Ann. Surg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neubiorev.2008.05.020","article-title":"Is neurogenic hypertension related to vascular inflammation of the brainstem?","volume":"33","author":"Paton","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1161\/HYPERTENSIONAHA.111.169748","article-title":"Autonomic-immune-vascular interaction: An emerging concept for neurogenic hypertension","volume":"57","author":"Zubcevic","year":"2011","journal-title":"Hypertension"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5494\/wjh.v4.i1.1","article-title":"Brain inflammation in neurogenic hypertension","volume":"4","author":"Waki","year":"2014","journal-title":"World J. Hypertens."},{"key":"ref_31","unstructured":"Melmed, S., Polonsky, K.S., Larsen, P.R., and Kronenberg, H.M. (2015). Williams Textbook of Endocrinology E-Book, Elsevier Health Sciences."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1046\/j.1440-1681.2000.03259.x","article-title":"Circumventricular organs: Definition and role in the regulation of endocrine and autonomic function","volume":"27","author":"Ganong","year":"2000","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12987-020-00228-x","article-title":"Permeability of the windows of the brain: Feasibility of dynamic contrast-enhanced MRI of the circumventricular organs","volume":"17","author":"Verheggen","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"ref_34","unstructured":"Oldfield, B.J., and McKinley, M.J. (2015). The Rat Nervous System, Elsevier."},{"key":"ref_35","unstructured":"Johnson, A. (2009). Encyclopedia of Neuroscience, Elsevier Ltd."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000123167","article-title":"The circumventricular organs and the central actions of angiotensin","volume":"32","author":"Simpson","year":"1981","journal-title":"Neuroendocrinology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1749-6632.1987.tb24959.x","article-title":"The role of angiotensin II in the regulation of ACTH secretion","volume":"512","author":"Ganong","year":"1987","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_38","unstructured":"Robinson, M.M., and Evered, M.D. (1986). The Physiology of Thirst and Sodium Appetite, Springer."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1212\/WNL.0b013e31822f04a0","article-title":"Circumventricular organs: Receptive and homeostatic functions and clinical implications","volume":"77","author":"Benarroch","year":"2011","journal-title":"Neurology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1517\/14728222.12.6.717","article-title":"The paraventricular nucleus of the hypothalamus\u2013a potential target for integrative treatment of autonomic dysfunction","volume":"12","author":"Ferguson","year":"2008","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"598469","DOI":"10.3389\/fnbeh.2020.598469","article-title":"The paraventricular nucleus of the thalamus is an important node in the emotional processing network","volume":"14","author":"Barson","year":"2020","journal-title":"Front. Behav. Neurosci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"858941","DOI":"10.3389\/fphys.2022.858941","article-title":"The Paraventricular Nucleus of the Hypothalamus in Control of Blood Pressure and Blood Pressure Variability","volume":"13","author":"Murphy","year":"2022","journal-title":"Front. Physiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1210\/en.2018-00453","article-title":"The paraventricular nucleus of the hypothalamus: Development, function, and human diseases","volume":"159","author":"Qin","year":"2018","journal-title":"Endocrinology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1055\/s-0032-1304624","article-title":"The vasculature within the paraventricular nucleus of the hypothalamus in mice varies as a function of development, subnuclear location, and GABA signaling","volume":"44","author":"Frahm","year":"2012","journal-title":"Horm. Metab. Res."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Cort\u00e9s-Sol, A., Lara-Garcia, M., Alvarado, M., Hudson, R., Berbel, P., and Pacheco, P. (2013). Inner capillary diameter of hypothalamic paraventricular nucleus of female rat increases during lactation. BMC Neurosci., 14.","DOI":"10.1186\/1471-2202-14-7"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1590\/S0100-879X2011007500088","article-title":"Angiotensin-II-induced reactive oxygen species along the SFO-PVN-RVLM pathway: Implications in neurogenic hypertension","volume":"44","author":"Braga","year":"2011","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/HYPERTENSIONAHA.116.07747","article-title":"Astrocytes contribute to angiotensin II stimulation of hypothalamic neuronal activity and sympathetic outflow","volume":"68","author":"Stern","year":"2016","journal-title":"Hypertension"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1113\/JP277043","article-title":"Shining light on the paraventricular nucleus: The role of glutamatergic PVN neurons in blood pressure control","volume":"596","author":"Becker","year":"2018","journal-title":"J. Physiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/01.HYP.0000259666.99449.74","article-title":"Glutamatergic inputs in the hypothalamic paraventricular nucleus maintain sympathetic vasomotor tone in hypertension","volume":"49","author":"Li","year":"2007","journal-title":"Hypertension"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1113\/JP276229","article-title":"Glutamatergic neurons of the paraventricular nucleus are critical contributors to the development of neurogenic hypertension","volume":"596","author":"Basting","year":"2018","journal-title":"J. Physiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"43038","DOI":"10.1038\/srep43038","article-title":"PVN blockade of p44\/42 MAPK pathway attenuates salt-induced hypertension through modulating neurotransmitters and attenuating oxidative stress","volume":"7","author":"Gao","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"AP386","DOI":"10.1161\/hyp.70.suppl_1.p386","article-title":"Abstract P386: The Paraventricular Nucleus in Control of Blood Pressure and Its Role in Hypertension","volume":"70","author":"Basting","year":"2017","journal-title":"Hypertension"},{"key":"ref_53","unstructured":"Fern\u00e1ndez-Gil, M.A., Palacios-Bote, R., Leo-Barahona, M., and Mora-Encinas, J. (2010). Seminars in Ultrasound, CT and MRI, Elsevier."},{"key":"ref_54","unstructured":"Nolte, J. (1981). The Human Brain: An Introduction to Its Functional Anatomy, Mosby Elsevier."},{"key":"ref_55","first-page":"A3","article-title":"The nucleus tractus solitarius: Neuroanatomic, neurochemical and functional aspects","volume":"99","author":"Jean","year":"1991","journal-title":"Arch. Int. Physiol. Biochim. Biophys."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1161\/CIRCRESAHA.109.208926","article-title":"Shift to an Involvement of PI3-Kinase in Angiotensin II Actions on Nucleus Tractus Solitarii Neurons of the Spontaneously Hypertensive Rat","volume":"105","author":"Sun","year":"2009","journal-title":"Circ. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0306-4522(92)90130-T","article-title":"Neurons in the rat medulla oblongata containing neuropeptide Y-, angiotensin II-, or galanin-like immunoreactivity project to the parabrachial nucleus","volume":"47","author":"Krukoff","year":"1992","journal-title":"Neuroscience"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/cne.902420405","article-title":"Projections from the nucleus tractus solitarii to the rostral ventrolateral medulla","volume":"242","author":"Ross","year":"1985","journal-title":"J. Comp. Neurol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1161\/HYPERTENSIONAHA.111.00156","article-title":"Chronic knockdown of the nucleus of the solitary tract AT1 receptors increases blood inflammatory-endothelial progenitor cell ratio and exacerbates hypertension in the spontaneously hypertensive rat","volume":"61","author":"Shan","year":"2013","journal-title":"Hypertension"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1161\/01.RES.32.5.584","article-title":"Acute fulminating neurogenic hypertension produced by brainstem lesions in the rat","volume":"32","author":"Doba","year":"1973","journal-title":"Circ. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/01.HYP.38.3.549","article-title":"Role of the medulla oblongata in hypertension","volume":"38","author":"Colombari","year":"2001","journal-title":"Hypertension"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1161\/HYPERTENSIONAHA.120.14521","article-title":"Neuronal networks in hypertension: Recent advances","volume":"76","author":"Guyenet","year":"2020","journal-title":"Hypertension"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"R985","DOI":"10.1152\/ajpregu.1991.261.4.R985","article-title":"Differentiation of two cardiovascular regions within caudal ventrolateral medulla","volume":"261","author":"Cravo","year":"1991","journal-title":"Am. J. Physiol.-Regul. Integr. Comp. Physiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1152\/physrev.1994.74.2.323","article-title":"Functional organization of central pathways regulating the cardiovascular system","volume":"74","author":"Dampney","year":"1994","journal-title":"Physiol. Rev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1590\/S0100-879X2008000700002","article-title":"Role of the caudal pressor area in the regulation of sympathetic vasomotor tone","volume":"41","author":"Campos","year":"2008","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/(SICI)1096-9861(19971103)387:4<524::AID-CNE4>3.0.CO;2-4","article-title":"Identification of C1 presympathetic neurons in rat rostral ventrolateral medulla by juxtacellular labeling in vivo","volume":"387","author":"Schreihofer","year":"1997","journal-title":"J. Comp. Neurol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/cne.902700311","article-title":"Ultrastructural characterization of substance P-like immunoreactive neurons in the rostral ventrolateral medulla in relation to neurons containing catecholamine-synthesizing enzymes","volume":"270","author":"Milner","year":"1988","journal-title":"J. Comp. Neurol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/cne.902680408","article-title":"Distributions of tyrosine hydroxylase-, dopamine-\u03b2-hydroxylase-, and phenylethanolamine-N-methyltransferase-immunoreactive neurons in the brain of the hamster (Mesocricetus auratus)","volume":"268","author":"Vincent","year":"1988","journal-title":"J. Comp. Neurol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1054-3589(10)58011-6","article-title":"Role of GABAB receptors in autonomic control of systemic blood pressure","volume":"58","author":"Li","year":"2010","journal-title":"Adv. Pharmacol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1113\/jphysiol.1988.sp016907","article-title":"Differential control of sympathetic fibres supplying hindlimb skin and muscle by subretrofacial neurones in the cat","volume":"395","author":"Dampney","year":"1988","journal-title":"J. Physiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1600-0773.1995.tb01032.x","article-title":"Angiotensin receptors in the brain","volume":"77","author":"Blume","year":"1995","journal-title":"Pharmacol. Toxicol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/HYPERTENSIONAHA.116.07914","article-title":"How Does Angiotensin Activate Hypothalamic Neurons Essential for Controlling Sympathetic Activity and Blood Pressure?","volume":"68","author":"Mendelowitz","year":"2016","journal-title":"Hypertension"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Toney, G.M., Pedrino, G.R., Fink, G.D., and Osborn, J.W. (2010). Does Enhanced Respiratory\u2013Sympathetic Coupling Contribute to Peripheral Neural Mechanisms of Angiotensin II\u2013Salt Hypertension?, Wiley Online Library.","DOI":"10.1113\/expphysiol.2009.047399"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Lin, S.-R., Lin, S.-Y., Chen, C.-C., Fu, Y.-S., and Weng, C.-F. (2019). Exploring a new natural treating agent for primary hypertension: Recent findings and forthcoming perspectives. J. Clin. Med., 8.","DOI":"10.3390\/jcm8112003"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.3389\/fphys.2019.01477","article-title":"Potential therapeutic use of neurosteroids for hypertension","volume":"10","author":"Head","year":"2019","journal-title":"Front. Physiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.3389\/fphys.2019.01311","article-title":"Mechanisms responsible for genetic hypertension in schlager BPH\/2 mice","volume":"10","author":"Jackson","year":"2019","journal-title":"Front. Physiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3389\/fphys.2018.00893","article-title":"Contribution of oxidative stress and inflammation to the neurogenic hypertension induced by intermittent hypoxia","volume":"9","author":"Oyarce","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.autneu.2008.07.001","article-title":"Gene expression profiles of major cytokines in the nucleus tractus solitarii of the spontaneously hypertensive rat","volume":"142","author":"Waki","year":"2008","journal-title":"Auton. Neurosci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.autneu.2008.07.003","article-title":"Specific inflammatory condition in nucleus tractus solitarii of the SHR: Novel insight for neurogenic hypertension?","volume":"142","author":"Waki","year":"2008","journal-title":"Auton. Neurosci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00395-011-0231-7","article-title":"Chronic exercise modulates RAS components and improves balance between pro-and anti-inflammatory cytokines in the brain of SHR","volume":"106","author":"Agarwal","year":"2011","journal-title":"Basic Res. Cardiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1161\/01.HYP.17.3.323","article-title":"Leukocyte counts and activation in spontaneously hypertensive and normotensive rats","volume":"17","author":"Seiffge","year":"1991","journal-title":"Hypertension"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1111\/j.1440-1681.2009.05234.x","article-title":"Brain cytokines as neuromodulators in cardiovascular control","volume":"37","author":"Shi","year":"2010","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.autneu.2018.01.002","article-title":"Neuroinflammation and sympathetic overactivity: Mechanisms and implications in hypertension","volume":"210","author":"Haspula","year":"2018","journal-title":"Auton. Neurosci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"8779","DOI":"10.1039\/C7RA09136B","article-title":"Angiotensin-(1-7) attenuates hypertension and cardiac hypertrophy via modulation of nitric oxide and neurotransmitter levels in the paraventricular nucleus in salt-sensitive hypertensive rats","volume":"8","author":"Liang","year":"2018","journal-title":"RSC Adv."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/HJH.0000000000001039","article-title":"2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents","volume":"34","author":"Lurbe","year":"2016","journal-title":"J. Hypertens."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/cc2351","article-title":"Clinical review: The management of hypertensive crises","volume":"7","author":"Varon","year":"2003","journal-title":"Crit. Care"},{"key":"ref_87","first-page":"866","article-title":"End organ damage in hypertension","volume":"107","author":"Schmieder","year":"2010","journal-title":"Dtsch. \u00c4rzteblatt Int."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1524-6175.2004.03610.x","article-title":"Lifestyle modifications for prevention and treatment of hypertension","volume":"6","author":"Kaplan","year":"2004","journal-title":"J. Clin. Hypertens."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4082\/kjfm.2017.38.4.173","article-title":"The effect of lifestyle changes on blood pressure control among hypertensive patients","volume":"38","author":"Yang","year":"2017","journal-title":"Korean J. Fam. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1021\/jf305064h","article-title":"Evaluation of Bamboo Shoot Peptide Preparation with Angiotensin Converting Enzyme Inhibitory and Antioxidant Abilities from Byproducts of Canned Bamboo Shoots","volume":"61","author":"Liu","year":"2013","journal-title":"J. Agric. Food Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"11351","DOI":"10.1021\/jf303471f","article-title":"Evaluation of antihypertensive and antihyperlipidemic effects of bamboo shoot angiotensin converting enzyme inhibitory peptide in vivo","volume":"60","author":"Liu","year":"2012","journal-title":"J. Agric. Food Chem."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1161\/HYP.0000000000000084","article-title":"Resistant hypertension: Detection, evaluation, and management: A scientific statement from the American Heart Association","volume":"72","author":"Carey","year":"2018","journal-title":"Hypertension"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"169","DOI":"10.12688\/f1000research.21669.1","article-title":"Recent advances in understanding and managing resistant\/refractory hypertension","volume":"9","author":"Doumas","year":"2020","journal-title":"F1000Research"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"H1706","DOI":"10.1152\/ajpheart.00885.2005","article-title":"Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension","volume":"290","author":"Krum","year":"2006","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0895-7061(03)00917-8","article-title":"Elevation of sympathetic activity by eprosartan in young male subjects","volume":"16","author":"Heusser","year":"2003","journal-title":"Am. J. Hypertens."},{"key":"ref_96","first-page":"884","article-title":"Addition of valsartan to an angiotensin-converting enzyme inhibitor improves cardiac sympathetic nerve activity and left ventricular function in patients with congestive heart failure","volume":"44","author":"Kasama","year":"2003","journal-title":"J. Nucl. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1161\/01.HYP.0000161880.59963.da","article-title":"Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension","volume":"45","author":"Doulton","year":"2005","journal-title":"Hypertension"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1161\/HYPERTENSIONAHA.114.03617","article-title":"Aging, arterial stiffness, and hypertension","volume":"65","author":"Sun","year":"2015","journal-title":"Hypertension"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.jacc.2018.01.058","article-title":"Angiotensin-converting enzyme inhibitors in hypertension: To use or not to use?","volume":"71","author":"Messerli","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_100","first-page":"S27","article-title":"Pharmacological mechanism of angiotensin II receptor antagonists: Implications for the treatment of elevated systolic blood pressure","volume":"17","author":"Brooks","year":"1999","journal-title":"J. Hypertension. Suppl. Off. J. Int. Soc. Hypertens."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1097\/01.ASN.0000143471.10750.8C","article-title":"Moxonidine normalizes sympathetic hyperactivity in patients with eprosartan-treated chronic renal failure","volume":"15","author":"Neumann","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/01.hjh.0000125453.28861.b8","article-title":"Rilmenidine sympatholytic activity preserves mental stress, orthostatic sympathetic responses and adrenaline secretion","volume":"22","author":"Esler","year":"2004","journal-title":"J. Hypertens."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1536\/jhj.44.693","article-title":"Short term effects of rilmenidine on left ventricular hypertrophy and systolic and diastolic function in patients with essential hypertension comparison with an angiotensin converting enzyme inhibitor and a calcium antagonist","volume":"44","author":"Koldas","year":"2003","journal-title":"Jpn. Heart J."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Fisher, J.P., and Fadel, P.J. (2010). Therapeutic Strategies for Targeting Excessive Central Sympathetic Activation in Human Hypertension, Wiley Online Library.","DOI":"10.1113\/expphysiol.2009.047332"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0140-6736(53)91589-X","article-title":"Sympathectomy in the treatment of hypertension review of 122 cases","volume":"261","author":"Morrissey","year":"1953","journal-title":"Lancet"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/01.CIR.6.1.131","article-title":"Sympathectomy for essential hypertension","volume":"6","author":"Allen","year":"1952","journal-title":"Circulation"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/00000658-195310000-00006","article-title":"Total thoracic and partial to total lumbar sympathectomy, splanchnicectomy and celiac ganglionectomy for hypertension","volume":"138","author":"Grimson","year":"1953","journal-title":"Ann. Surg."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1001\/jama.1948.02890410001001","article-title":"Sympathetic Innervation of the Heart in Man: Preliminary Observations of the Effect of Thoracic Sympathectomy on Heart Rate","volume":"137","author":"CHAPMAN","year":"1948","journal-title":"J. Am. Med. Assoc."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.hlc.2019.06.723","article-title":"Renal artery denervation in resistant hypertension: The good, the bad and the future","volume":"29","author":"Pouliopoulos","year":"2020","journal-title":"Heart Lung Circ."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1161\/HYPERTENSIONAHA.118.10265","article-title":"Renal Denervation: A treatment for hypertension and chronic kidney disease","volume":"72","author":"Singh","year":"2018","journal-title":"Hypertension"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(09)60566-3","article-title":"Catheter-based renal sympathetic denervation for resistant hypertension: A multicentre safety and proof-of-principle cohort study","volume":"373","author":"Krum","year":"2009","journal-title":"Lancet"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0140-6736(13)62192-3","article-title":"Percutaneous renal denervation in patients with treatment-resistant hypertension: Final 3-year report of the Symplicity HTN-1 study","volume":"383","author":"Krum","year":"2014","journal-title":"Lancet"},{"key":"ref_113","first-page":"S13","article-title":"Differentiation in the effects of the angiotensin II receptor blocker class on autonomic function","volume":"20","author":"Esler","year":"2002","journal-title":"J. Hypertension. Suppl. Off. J. Int. Soc. Hypertens."},{"key":"ref_114","unstructured":"F.N. RELEASE (2022, October 24). FDA Approves New Device to Improve Symptoms in Patients with Advanced Heart Failure, Available online: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-device-improve-symptoms-patients-advanced-heart-failure."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"83","DOI":"10.15420\/usc.2019.13.2","article-title":"Baroreflex Activation Therapy for Resistant Hypertension and Heart Failure","volume":"13","author":"Kristensen","year":"2020","journal-title":"J. US Cardiol. Rev."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrcardio.2015.96","article-title":"Carotid baroreflex activation therapy for resistant hypertension","volume":"12","author":"Victor","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"E28","DOI":"10.1093\/eurheartjsupp\/suac031","article-title":"Current and future use of neuromodulation in heart failure","volume":"24","author":"Duncker","year":"2022","journal-title":"Eur. Heart J. Suppl."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00004872-199816040-00013","article-title":"Haemodynamic and sympathetic effects of inhibition of nitric oxide synthase by systemic infusion of NG-monomethyl-L-arginine into humans are dose dependent","volume":"16","author":"Lepori","year":"1998","journal-title":"J. Hypertens."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1161\/01.HYP.33.4.937","article-title":"A large blood pressure\u2013raising effect of nitric oxide synthase inhibition in humans","volume":"33","author":"Sander","year":"1999","journal-title":"Hypertension"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1440-1681.2008.05123.x","article-title":"Role of L-arginine in nitric oxide production in health and hypertension","volume":"36","author":"Rajapakse","year":"2008","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/14728222.2017.1310840","article-title":"The potential of stimulating nitric oxide formation in the treatment of hypertension","volume":"21","author":"Pinheiro","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199702273360902","article-title":"Inhaled nitric oxide and persistent pulmonary hypertension of the newborn","volume":"336","author":"Roberts","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_123","unstructured":"Gastelurrutia, P., Lup\u00f3n, J., De Antonio, M., Urrutia, A., D\u00edez, C., Coll, R., Altimir, S., and Bayes-Genis, A. (2012). Mayo Clinic Proceedings, Elsevier."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/bja\/ael358","article-title":"Beneficial effects of statins on the microcirculation during sepsis: The role of nitric oxide","volume":"98","author":"McGown","year":"2007","journal-title":"Br. J. Anaesth."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.it.2006.12.003","article-title":"Statins and the vascular endothelial inflammatory response","volume":"28","author":"Greenwood","year":"2007","journal-title":"Trends Immunol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.atherosclerosissup.2006.01.005","article-title":"Statins: Potential new indications in inflammatory conditions","volume":"7","author":"Endres","year":"2006","journal-title":"Atheroscler. Suppl."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1161\/01.CIR.0000065606.63163.B9","article-title":"Simvastatin normalizes autonomic neural control in experimental heart failure","volume":"107","author":"Pliquett","year":"2003","journal-title":"Circulation"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1152\/japplphysiol.00265.2003","article-title":"Statin therapy restores sympathovagal balance in experimental heart failure","volume":"95","author":"Pliquett","year":"2003","journal-title":"J. Appl. Physiol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1111\/j.1755-5922.2010.00137.x","article-title":"Natural antioxidants and hypertension: Promise and challenges","volume":"28","author":"Kizhakekuttu","year":"2010","journal-title":"Cardiovasc. Ther."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"12686","DOI":"10.1039\/D2FO01746F","article-title":"Whole grain benefit: Synergistic effect of oat phenolic compounds and \u03b2-glucan on hyperlipidemia via gut microbiota in high-fat-diet mice","volume":"13","author":"Li","year":"2022","journal-title":"Food Funct."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"101946","DOI":"10.1016\/j.fbio.2022.101946","article-title":"Oat phenolic compounds regulate metabolic syndrome in high fat diet-fed mice via gut microbiota","volume":"50","author":"Dong","year":"2022","journal-title":"Food Biosci."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fphys.2018.00258","article-title":"The antioxidant therapy: New insights in the treatment of hypertension","volume":"9","author":"Sorriento","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"134231","DOI":"10.1016\/j.foodchem.2022.134231","article-title":"The positive correlation of antioxidant activity and prebiotic effect about oat phenolic compounds","volume":"402","author":"Zhang","year":"2023","journal-title":"Food Chem."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2045-8118-8-2","article-title":"Fluids and barriers of the CNS: A historical viewpoint","volume":"8","author":"Liddelow","year":"2011","journal-title":"Fluids Barriers CNS"},{"key":"ref_135","first-page":"1","article-title":"The cerebral circulation","volume":"1","author":"Cipolla","year":"2009","journal-title":"Integr. Syst. Physiol. Mol. Funct."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.resp.2011.05.004","article-title":"Contributions of vascular inflammation in the brainstem for neurogenic hypertension","volume":"178","author":"Waki","year":"2011","journal-title":"Respir. Physiol. Neurobiol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1113\/EP086434","article-title":"The role of the blood\u2013brain barrier in hypertension","volume":"103","author":"Setiadi","year":"2018","journal-title":"Exp. Physiol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/HYPERTENSIONAHA.121.17049","article-title":"Blood-brain barrier crossing renin-angiotensin drugs and cognition in the elderly: A meta-analysis","volume":"78","author":"Ho","year":"2021","journal-title":"Hypertension"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.3109\/10641968309051803","article-title":"Effect of the intracerebroventricular injection of dopamine on blood pressure in the spontaneously hypertensive rat","volume":"5","author":"Kawabe","year":"1983","journal-title":"Clin. Exp. Hypertension. Part A Theory Pract."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/00005344-199906000-00007","article-title":"Central effects of endothelin and its antagonists on sympathetic and cardiovascular regulation in SHR-SP","volume":"33","author":"Nakamura","year":"1999","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/0895-7061(96)00171-9","article-title":"GABAB-ergic stimulation in hypothalamic pressor area induces larger sympathetic and cardiovascular depression in spontaneously hypertensive rats","volume":"9","author":"Takenaka","year":"1996","journal-title":"Am. J. Hypertens."},{"key":"ref_142","unstructured":"Kumar, A., Roy, S., Srivastava, A., Naikwade, M.M., Purohit, B., Mahato, K., Naidu, V., and Chandra, P. (2019). Nanotechnology in Modern Animal Biotechnology, Elsevier."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.biopha.2017.11.026","article-title":"Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world","volume":"97","author":"Prasad","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_144","unstructured":"Arora, S., Trivedi, R., Lamptey, R.N., Chaulagain, B., Layek, B., and Singh, J. (2021). Tailor-Made and Functionalized Biopolymer Systems, Elsevier."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/s41578-020-0230-0","article-title":"Synthetic amorphous silica nanoparticles: Toxicity, biomedical and environmental implications","volume":"5","author":"Croissant","year":"2020","journal-title":"Nat. Rev. Mater."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Lamptey, R.N.L., Chaulagain, B., Trivedi, R., Gothwal, A., Layek, B., and Singh, J. (2022). A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031851"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1904399","DOI":"10.1002\/adfm.201904399","article-title":"Surface engineered polymersomes for enhanced modulation of dendritic cells during cardiovascular immunotherapy","volume":"29","author":"Yi","year":"2019","journal-title":"Adv. Funct. Mater."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"8382","DOI":"10.1038\/s41598-020-65255-y","article-title":"Administration of apo AI (Milano) nanoparticles reverses pathological remodelling, cardiac dysfunction, and heart failure in a murine model of HFpEF associated with hypertension","volume":"10","author":"Mishra","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1161\/HYPERTENSIONAHA.118.12005","article-title":"Potential strategies to reduce blood pressure in treatment-resistant hypertension using food and drug administration\u2013approved nanodrug delivery platforms","volume":"73","author":"Fancher","year":"2019","journal-title":"Hypertension"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/s41578-021-00392-y","article-title":"Nebulized lipid nanoparticles","volume":"6","author":"Horejs","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"11228","DOI":"10.1038\/s41598-022-14688-8","article-title":"Use of giant unilamellar lipid vesicles as antioxidant carriers in in vitro culture medium of bovine embryos","volume":"12","author":"Rossi","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i6.10","article-title":"Lipid-based nanoparticles as pharmaceutical drug carriers: From concepts to clinic","volume":"26","author":"Puri","year":"2009","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Editorial (2021). Let\u2019s talk about lipid nanoparticles. Nat. Rev. Mater., 6, 99.","DOI":"10.1038\/s41578-021-00281-4"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"146738","DOI":"10.1016\/j.brainres.2020.146738","article-title":"Efficient neuronal targeting and transfection using RVG and transferrin-conjugated liposomes","volume":"1734","author":"Arora","year":"2020","journal-title":"Brain Res."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.colsurfb.2018.09.047","article-title":"Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model","volume":"173","author":"Lakkadwala","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid Nanoparticles\u2014From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2174\/1389200211314060001","article-title":"Nanoparticle- and liposome-carried drugs: New strategies for active targeting and drug delivery across blood-brain barrier","volume":"14","author":"Campia","year":"2013","journal-title":"Curr. Drug Metab."},{"key":"ref_159","unstructured":"Trivedi, R., Arora, S., Lamptey, R.N., Chaulagain, B., Singh, J., and Layek, B. (2022). Nanotherapeutics for the Treatment of Hepatocellular Carcinoma, Bentham Science Publishers."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1021\/acs.molpharmaceut.0c00461","article-title":"Design and validation of liposomal ApoE2 gene delivery system to evade blood\u2013brain barrier for effective treatment of Alzheimer\u2019s disease","volume":"18","author":"Arora","year":"2020","journal-title":"Mol. Pharm."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00003495-199700544-00005","article-title":"Polyethylene glycol-coated (pegylated) liposomal doxorubicin","volume":"54","author":"Gabizon","year":"1997","journal-title":"Drugs"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.chemphyslip.2013.10.011","article-title":"Novel methods for liposome preparation","volume":"177","author":"Patil","year":"2014","journal-title":"Chem. Phys. Lipids"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1161\/01.HYP.15.6.600","article-title":"In vivo hypertensive arterial wall uptake of radiolabeled liposomes","volume":"15","author":"Hodis","year":"1990","journal-title":"Hypertension"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"e004594","DOI":"10.1161\/JAHA.116.004594","article-title":"Knockdown of Inhibitory Guanine Nucleotide Binding Protein Gi\u03b1-2 by Antisense Oligodeoxynucleotides Attenuates the Development of Hypertension and Tachycardia in Spontaneously Hypertensive Rats","volume":"5","author":"Li","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/01.HYP.28.1.147","article-title":"Inhibition of hypertension by peripheral administration of antisense oligodeoxynucleotides","volume":"28","author":"Wielbo","year":"1996","journal-title":"Hypertension"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/01.CIR.95.3.588","article-title":"Role of superoxide in angiotensin II\u2013induced but not catecholamine-induced hypertension","volume":"95","author":"Laursen","year":"1997","journal-title":"Circulation"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jconrel.2018.07.043","article-title":"Dual functionalized liposome-mediated gene delivery across triple co-culture blood brain barrier model and specific in vivo neuronal transfection","volume":"286","author":"Oue","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/01.CIR.99.17.2302","article-title":"Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: A model for pseudoallergic cardiopulmonary reactions to liposomes: Role of complement and inhibition by soluble CR1 and anti-C5a antibody","volume":"99","author":"Szebeni","year":"1999","journal-title":"Circulation"},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Satapathy, M.K., Yen, T.-L., Jan, J.-S., Tang, R.-D., Wang, J.-Y., Taliyan, R., and Yang, C.-H. (2021). Solid lipid nanoparticles (SLNs): An advanced drug delivery system targeting brain through BBB. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13081183"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4103\/0250-474X.57282","article-title":"Solid lipid nanoparticles: A modern formulation approach in drug delivery system","volume":"71","author":"Mukherjee","year":"2009","journal-title":"Indian J. Pharm. Sci."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Pinel, B., Porras-Alcal\u00e1, C., Ortega-Rodr\u00edguez, A., Sarabia, F., Prados, J., Melguizo, C., and L\u00f3pez-Romero, J.M. (2019). Lipid-based nanoparticles: Application and recent advances in cancer treatment. Nanomaterials, 9.","DOI":"10.3390\/nano9040638"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/2211738506666180611100416","article-title":"Lipid nanoparticles: A novel approach for brain targeting","volume":"6","author":"Shankar","year":"2018","journal-title":"Pharm. Nanotechnol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.bmcl.2016.04.007","article-title":"Cholesterol derived cationic lipids as potential non-viral gene delivery vectors and their serum compatibility","volume":"26","author":"Ju","year":"2016","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"495103","DOI":"10.1088\/0957-4484\/26\/49\/495103","article-title":"Solid lipid nanoparticles as a vehicle for brain-targeted drug delivery: Two new strategies of functionalization with apolipoprotein E","volume":"26","author":"Neves","year":"2015","journal-title":"Nanotechnology"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.colsurfb.2018.02.011","article-title":"Solid lipid nanoparticles as an efficient drug delivery system of olmesartan medoxomil for the treatment of hypertension","volume":"165","author":"Pandya","year":"2018","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.nano.2011.08.016","article-title":"Solid lipid nanoparticles loading candesartan cilexetil enhance oral bioavailability: In vitro characteristics and absorption mechanism in rats","volume":"8","author":"Zhang","year":"2012","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3109\/10717544.2014.914986","article-title":"Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: Characterization, pharmacokinetic and pharmacodynamic evaluation","volume":"23","author":"Dudhipala","year":"2016","journal-title":"Drug Deliv."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2174\/1567201813666161230141717","article-title":"Formulation and optimization of candesartan cilexetil nano lipid carrier: In vitro and in vivo evaluation","volume":"14","author":"Paudel","year":"2017","journal-title":"Curr. Drug Deliv."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.3109\/03639045.2015.1024685","article-title":"Pharmacokinetic and pharmacodynamic studies of nisoldipine-loaded solid lipid nanoparticles developed by central composite design","volume":"41","author":"Dudhipala","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_180","first-page":"218","article-title":"Isradipine loaded solid lipid nanoparticles for better treatment of hypertension\u2013preparation, characterization and in vivo evaluation","volume":"5","author":"Havanoor","year":"2014","journal-title":"Int. J. Biopharm."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"212","DOI":"10.22270\/jddt.v9i3.2849","article-title":"Formulation of solid lipid nanoparticles of cilnidipine for the treatment of hypertension","volume":"9","author":"Bhalerao","year":"2019","journal-title":"J. Drug Deliv. Ther."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"e09403","DOI":"10.1016\/j.heliyon.2022.e09403","article-title":"Lipid Based Nanoparticles For Treatment Of Cancer","volume":"8","author":"Sheoran","year":"2022","journal-title":"Heliyon"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jsps.2021.07.015","article-title":"Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies","volume":"29","author":"Elmowafy","year":"2021","journal-title":"Saudi Pharm. J."},{"key":"ref_184","first-page":"1547","article-title":"Enhancement Of Bioavilability of Perinodopril Using Lipid Based Nanocarrier Mediated Oral Drug Delivery System","volume":"6","author":"Pg","year":"2022","journal-title":"J. Posit. Sch. Psychol."},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Eleraky, N.E., Omar, M.M., Mahmoud, H.A., and Abou-Taleb, H.A. (2020). Nanostructured lipid carriers to mediate brain delivery of temazepam: Design and in vivo study. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12050451"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s13346-021-00958-x","article-title":"Nanostructured lipid carriers of isradipine for effective management of hypertension and isoproterenol induced myocardial infarction","volume":"12","author":"Alam","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.colsurfb.2017.03.006","article-title":"Nanostructured lipid carriers of olmesartan medoxomil with enhanced oral bioavailability","volume":"154","author":"Kaithwas","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/adt.2021.084","article-title":"Formulation of Lipid-Based Nanocarriers of Lacidipine for Improvement of Oral Delivery: Box-Behnken Design Optimization, In Vitro, Ex Vivo, and Preclinical Assessment","volume":"20","author":"Kataria","year":"2022","journal-title":"ASSAY Drug Dev. Technol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"FSO135","DOI":"10.4155\/fsoa-2016-0030","article-title":"Nanostructured lipid carriers: Versatile oral delivery vehicle","volume":"2","author":"Poonia","year":"2016","journal-title":"Future Sci. OA"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.2147\/DDDT.S90016","article-title":"Improvement of oral bioavailability of lovastatin by using nanostructured lipid carriers","volume":"9","author":"Zhou","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Zieli\u0144ska, A., Carreir\u00f3, F., Oliveira, A.M., Neves, A., Pires, B., Venkatesh, D.N., Durazzo, A., Lucarini, M., Eder, P., and Silva, A.M. (2020). Polymeric nanoparticles: Production, characterization, toxicology and ecotoxicology. Molecules, 25.","DOI":"10.3390\/molecules25163731"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1021\/bm301720g","article-title":"Amino acid grafted chitosan for high performance gene delivery: Comparison of amino acid hydrophobicity on vector and polyplex characteristics","volume":"14","author":"Layek","year":"2013","journal-title":"Biomacromolecules"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41392-022-01082-z","article-title":"Nanoparticles in the diagnosis and treatment of vascular aging and related diseases","volume":"7","author":"Xu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1701276","DOI":"10.1002\/adhm.201701276","article-title":"Engineering polymersomes for diagnostics and therapy","volume":"7","author":"Leong","year":"2018","journal-title":"Adv. Healthc. Mater."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1055\/s-0042-110931","article-title":"Study of copolymer composition on drug loading efficiency of enalapril in polymersomes and cytotoxicity of drug loaded nanoparticles","volume":"66","author":"Danafar","year":"2016","journal-title":"Drug Res."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.foodhyd.2010.03.003","article-title":"Biological activities of chitosan and chitooligosaccharides","volume":"25","author":"Xia","year":"2011","journal-title":"Food Hydrocoll."},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"Lamptey, R.N.L., Gothwal, A., Trivedi, R., Arora, S., and Singh, J. (2022). Synthesis and Characterization of Fatty Acid Grafted Chitosan Polymeric Micelles for Improved Gene Delivery of VGF to the Brain through Intranasal Route. Biomedicines, 10.","DOI":"10.3390\/biomedicines10020493"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1166\/jnd.2013.1014","article-title":"Exploring lecithin\/chitosan nanoparticles of ramipril for improved antihypertensive efficacy","volume":"1","author":"Chadha","year":"2013","journal-title":"J. Nanopharm. Drug Deliv."},{"key":"ref_199","first-page":"118","article-title":"Preparation, characterization and evaluation of nebivolol loaded chitosan nanoparticles","volume":"8","author":"Sharma","year":"2018","journal-title":"J. Drug Deliv. Ther."},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Auwal, S.M., Zarei, M., Tan, C.P., Basri, M., and Saari, N. (2017). Improved in vivo efficacy of anti-hypertensive biopeptides encapsulated in chitosan nanoparticles fabricated by ionotropic gelation on spontaneously hypertensive rats. Nanomaterials, 7.","DOI":"10.3390\/nano7120421"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4142\/jvs.2009.10.2.141","article-title":"NaCl plus chitosan as a dietary salt to prevent the development of hypertension in spontaneously hypertensive rats","volume":"10","author":"Park","year":"2009","journal-title":"J. Vet. Sci."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"107910","DOI":"10.1016\/j.foodhyd.2022.107910","article-title":"Citrus pectin research advances: Derived as a biomaterial in the construction and applications of micro\/nano-delivery systems","volume":"133","author":"Liu","year":"2022","journal-title":"Food Hydrocoll."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"783641","DOI":"10.3389\/fphar.2021.783641","article-title":"Cardiovascular protective effects of plant polysaccharides: A review","volume":"12","author":"Dong","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.ijbiomac.2021.07.008","article-title":"Anti-hypertensive and cardioprotective activities of traditional Chinese medicine-derived polysaccharides: A review","volume":"185","author":"Xie","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"10075","DOI":"10.1021\/acs.jafc.2c04241","article-title":"Research Advances of Lactoferrin in Electrostatic Spinning, Nano Self-Assembly, and Immune and Gut Microbiota Regulation","volume":"70","author":"Li","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1074\/jbc.274.11.7011","article-title":"Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier","volume":"274","author":"Fillebeen","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.ijbiomac.2020.07.167","article-title":"Lactoferrin, a unique molecule with diverse therapeutical and nanotechnological applications","volume":"164","author":"Sabra","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_208","first-page":"1","article-title":"Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applications","volume":"11","author":"Kalomiraki","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1039\/C4TB00171K","article-title":"Dendrimers for drug delivery","volume":"2","author":"Caminade","year":"2014","journal-title":"J. Mater. Chem. B"},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Chauhan, A.S. (2018). Dendrimers for drug delivery. Molecules, 23.","DOI":"10.3390\/molecules23040938"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1461-5347(99)00203-5","article-title":"Designing dendrimers for drug delivery","volume":"2","author":"Liu","year":"1999","journal-title":"Pharm. Sci. Technol. Today"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ejmech.2009.10.017","article-title":"Designing dendrimers for ocular drug delivery","volume":"45","author":"Spataro","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.addr.2013.01.001","article-title":"Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: A concise overview","volume":"65","author":"Mignani","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejps.2016.09.005","article-title":"Poly (amidoamine) dendrimer-mediated hybrid formulation for combination therapy of ramipril and hydrochlorothiazide","volume":"96","author":"Singh","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejps.2014.06.024","article-title":"Surface modified PLGA nanoparticles for brain targeting of Bacoside-A","volume":"63","author":"Jose","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"587012","DOI":"10.3389\/fmolb.2020.587012","article-title":"Nanoparticle surface functionalization: How to improve biocompatibility and cellular internalization","volume":"7","author":"Carrese","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/cbin.10459","article-title":"Effect of the surface modification, size, and shape on cellular uptake of nanoparticles","volume":"39","author":"Salatin","year":"2015","journal-title":"Cell Biol. Int."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jconrel.2020.09.008","article-title":"Bioresponsive drug delivery systems for the treatment of inflammatory diseases","volume":"327","author":"Dou","year":"2020","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"6300","DOI":"10.1021\/acs.jafc.2c01080","article-title":"Recent Advances of Stimuli-Responsive Polysaccharide Hydrogels in Delivery Systems: A Review","volume":"70","author":"Zhang","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12325-019-01148-5","article-title":"Pathophysiology and therapeutic perspectives of oxidative stress and neurodegenerative diseases: A narrative review","volume":"37","author":"Rekatsina","year":"2020","journal-title":"Adv. Ther."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1021\/cm3037197","article-title":"Bioresponsive controlled drug release based on mesoporous silica nanoparticles coated with reductively sheddable polymer shell","volume":"25","author":"Chang","year":"2013","journal-title":"Chem. Mater."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"6729","DOI":"10.1021\/acsnano.9b09991","article-title":"Dual-sensitive nanomicelles enhancing systemic delivery of therapeutically active antibodies specifically into the brain","volume":"14","author":"Xie","year":"2020","journal-title":"ACS Nano"},{"key":"ref_223","first-page":"439","article-title":"Non-invasive strategies for nose-to-brain drug delivery","volume":"10","author":"Trevino","year":"2020","journal-title":"J. Clin. Trials"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1517\/17425247.5.10.1159","article-title":"From nose to brain: Understanding transport capacity and transport rate of drugs","volume":"5","author":"Wu","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1124\/jpet.119.258152","article-title":"Nose-to-brain delivery","volume":"370","author":"Wang","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41392-021-00591-7","article-title":"The olfactory route is a potential way for SARS-CoV-2 to invade the central nervous system of rhesus monkeys","volume":"6","author":"Jiao","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_227","doi-asserted-by":"crossref","unstructured":"Nampoothiri, S., Sauve, F., Ternier, G., Fernandois, D., Coelho, C., Imbernon, M., Deligia, E., Perbet, R., Florent, V., and Baroncini, M. (2020). The hypothalamus as a hub for SARS-CoV-2 brain infection and pathogenesis. BioRxiv.","DOI":"10.1101\/2020.06.08.139329"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2213\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:13:33Z","timestamp":1760120013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,22]]},"references-count":227,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["ijms24032213"],"URL":"https:\/\/doi.org\/10.3390\/ijms24032213","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,22]]}}}